These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 1501588

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Heterogeneity of EBV-transformable human B lymphocyte populations.
    Chan MA, Stein LD, Dosch HM, Sigal NH.
    J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
    [Abstract] [Full Text] [Related]

  • 24. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2.
    Wakasugi N, Tagaya Y, Wakasugi H, Mitsui A, Maeda M, Yodoi J, Tursz T.
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8282-6. PubMed ID: 2172979
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. B-cell-derived IL-10: production and function.
    Burdin N, Rousset F, Banchereau J.
    Methods; 1997 Jan; 11(1):98-111. PubMed ID: 8990095
    [Abstract] [Full Text] [Related]

  • 28. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
    Park CH, Kim HR, Kim J, Jang SH, Lee KY, Chung GH, Jang YS.
    J Cell Biochem; 2004 Mar 01; 91(4):777-85. PubMed ID: 14991769
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Induction of B cell responsiveness to growth factors by Epstein-Barr virus conversion: comparison of endogenous factors and interleukin-1.
    Blazar BA, Murphy AM.
    Clin Exp Immunol; 1990 Apr 01; 80(1):62-8. PubMed ID: 2157568
    [Abstract] [Full Text] [Related]

  • 36. Effect of cytokines on proliferation of Epstein Barr virus-transformed B lymphocytes.
    Richter W, Eiermann TH, Scherbaum WA.
    Hybridoma; 1990 Feb 01; 9(1):1-8. PubMed ID: 2155870
    [Abstract] [Full Text] [Related]

  • 37. TIMP-1/MMP-9 imbalance in an EBV-immortalized B lymphocyte cellular model: evidence for TIMP-1 multifunctional properties.
    Gaudin P, Trocmé C, Berthier S, Kieffer S, Boutonnat J, Lamy C, Surla A, Garin J, Morel F.
    Biochim Biophys Acta; 2000 Dec 11; 1499(1-2):19-33. PubMed ID: 11118636
    [Abstract] [Full Text] [Related]

  • 38. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells.
    Tosato G, Tanner J, Jones KD, Revel M, Pike SE.
    J Virol; 1990 Jun 11; 64(6):3033-41. PubMed ID: 2159561
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.